Global Vital Signs Monitoring Market
Global Vital Signs Monitoring Market

Vital Signs Monitoring Comprehensive Study by Application (Hospitals and Clinics, Ambulatory Centers, Home Healthcare, Others), Distribution Chanel (Hospital Pharmacy, Retail Pharmacies, Online Websites, Others), Portability (Standalone, Portable) Players and Region - Global Market Outlook to 2024

Vital Signs Monitoring Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

May 2019 Edition 222 Pages 224 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study
Vital sign monitoring is an assessment of heart rate, respiratory rate, blood pressure, oxygen saturation and body temperature. Vital signs are the baseline indicators of the patientís current health status. Vital signs are never stagnant because of the effect of a variety of internal and external factors such as many disease conditions, anxiety, pain, exercise etc. Vital sign monitoring devices are used to monitor the vital signs of the patient.

The market study is being classified, by Application (Hospitals and Clinics, Ambulatory Centers, Home Healthcare and Others) and major geographies with country level break-up.

A&D Company (Japan), Contec Medical Systems (China), GE Healthcare (United States), Masimo Corporation (United States), Mindray Medical International Limited (China), Nihon Kohden (Japan), Omron Healthcare, Inc. (United States), Philips Healthcare (Netherlands), Spacelabs Healthcare, Inc. (United States) and SunTech Medical (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Welch Allyn, Inc. (United States), Boston Scientific (United States) and Natus Medical Incorporated (United States).

Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Vital Signs Monitoring market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Vital Signs Monitoring market by Type, Application and Region.

On the basis of geography, the market of Vital Signs Monitoring has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Chanel, the sub-segment i.e. Hospital Pharmacy will boost the Vital Signs Monitoring market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Portability, the sub-segment i.e. Standalone will boost the Vital Signs Monitoring market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Rising Prevalence of Diseases
  • Growing Geriatric Population and Chronic Disease
  • Increasing Demand for Portable Devices

Market Trend
  • Technological Advancements in Devices

Restraints
  • Pricing Pressure of Devices

Opportunities
  • Increase in the Healthcare Expenditure in Emerging Economies

Challenges
  • Lack of Awareness about Devices


On 9th July 2018, Masimo released vital signs check application, an integrated patient data collection and workflow application for the Masimo Root patient monitoring and connectivity platform. Vital Signs Check, available for new and existing Root customers through a software upgrade, augments Rootís versatility by helping to automate hospital vital signs testing workflows.


Key Target Audience
Vital Signs Monitoring Device Manufacturers, Raw Material Suppliers/ Buyers, Distributors, Government Body & Associations and End-user

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Application
  • Hospitals and Clinics
  • Ambulatory Centers
  • Home Healthcare
  • Others
By Distribution Chanel
  • Hospital Pharmacy
  • Retail Pharmacies
  • Online Websites
  • Others

By Portability
  • Standalone
  • Portable

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Diseases
      • 3.2.2. Growing Geriatric Population and Chronic Disease
      • 3.2.3. Increasing Demand for Portable Devices
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness about Devices
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements in Devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Vital Signs Monitoring, by Application, Distribution Chanel, Portability and Region (value, volume and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Vital Signs Monitoring (Value)
      • 5.2.1. Global Vital Signs Monitoring by: Application (Value)
        • 5.2.1.1. Hospitals and Clinics
        • 5.2.1.2. Ambulatory Centers
        • 5.2.1.3. Home Healthcare
        • 5.2.1.4. Others
      • 5.2.2. Global Vital Signs Monitoring by: Distribution Chanel (Value)
        • 5.2.2.1. Hospital Pharmacy
        • 5.2.2.2. Retail Pharmacies
        • 5.2.2.3. Online Websites
        • 5.2.2.4. Others
      • 5.2.3. Global Vital Signs Monitoring by: Portability (Value)
        • 5.2.3.1. Standalone
        • 5.2.3.2. Portable
      • 5.2.4. Global Vital Signs Monitoring Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Vital Signs Monitoring (Volume)
      • 5.3.1. Global Vital Signs Monitoring by: Application (Volume)
        • 5.3.1.1. Hospitals and Clinics
        • 5.3.1.2. Ambulatory Centers
        • 5.3.1.3. Home Healthcare
        • 5.3.1.4. Others
      • 5.3.2. Global Vital Signs Monitoring by: Distribution Chanel (Volume)
        • 5.3.2.1. Hospital Pharmacy
        • 5.3.2.2. Retail Pharmacies
        • 5.3.2.3. Online Websites
        • 5.3.2.4. Others
      • 5.3.3. Global Vital Signs Monitoring by: Portability (Volume)
        • 5.3.3.1. Standalone
        • 5.3.3.2. Portable
      • 5.3.4. Global Vital Signs Monitoring Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Vital Signs Monitoring (Price)
  • 6. Vital Signs Monitoring: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. A&D Company (Japan)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Contec Medical Systems (China)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. GE Healthcare (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Masimo Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Mindray Medical International Limited (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Nihon Kohden (Japan)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Omron Healthcare, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Philips Healthcare (Netherlands)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Spacelabs Healthcare, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. SunTech Medical (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Vital Signs Monitoring Sale, by Application, Distribution Chanel, Portability and Region (value, volume and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Vital Signs Monitoring (Value)
      • 7.2.1. Global Vital Signs Monitoring by: Application (Value)
        • 7.2.1.1. Hospitals and Clinics
        • 7.2.1.2. Ambulatory Centers
        • 7.2.1.3. Home Healthcare
        • 7.2.1.4. Others
      • 7.2.2. Global Vital Signs Monitoring by: Distribution Chanel (Value)
        • 7.2.2.1. Hospital Pharmacy
        • 7.2.2.2. Retail Pharmacies
        • 7.2.2.3. Online Websites
        • 7.2.2.4. Others
      • 7.2.3. Global Vital Signs Monitoring by: Portability (Value)
        • 7.2.3.1. Standalone
        • 7.2.3.2. Portable
      • 7.2.4. Global Vital Signs Monitoring Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Vital Signs Monitoring (Volume)
      • 7.3.1. Global Vital Signs Monitoring by: Application (Volume)
        • 7.3.1.1. Hospitals and Clinics
        • 7.3.1.2. Ambulatory Centers
        • 7.3.1.3. Home Healthcare
        • 7.3.1.4. Others
      • 7.3.2. Global Vital Signs Monitoring by: Distribution Chanel (Volume)
        • 7.3.2.1. Hospital Pharmacy
        • 7.3.2.2. Retail Pharmacies
        • 7.3.2.3. Online Websites
        • 7.3.2.4. Others
      • 7.3.3. Global Vital Signs Monitoring by: Portability (Volume)
        • 7.3.3.1. Standalone
        • 7.3.3.2. Portable
      • 7.3.4. Global Vital Signs Monitoring Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Vital Signs Monitoring (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Vital Signs Monitoring: by Application(USD Million)
  • Table 2. Vital Signs Monitoring Hospitals and Clinics , by Region USD Million (2013-2018)
  • Table 3. Vital Signs Monitoring Ambulatory Centers , by Region USD Million (2013-2018)
  • Table 4. Vital Signs Monitoring Home Healthcare , by Region USD Million (2013-2018)
  • Table 5. Vital Signs Monitoring Others , by Region USD Million (2013-2018)
  • Table 6. Vital Signs Monitoring: by Distribution Chanel(USD Million)
  • Table 7. Vital Signs Monitoring Hospital Pharmacy , by Region USD Million (2013-2018)
  • Table 8. Vital Signs Monitoring Retail Pharmacies , by Region USD Million (2013-2018)
  • Table 9. Vital Signs Monitoring Online Websites , by Region USD Million (2013-2018)
  • Table 10. Vital Signs Monitoring Others , by Region USD Million (2013-2018)
  • Table 11. Vital Signs Monitoring: by Portability(USD Million)
  • Table 12. Vital Signs Monitoring Standalone , by Region USD Million (2013-2018)
  • Table 13. Vital Signs Monitoring Portable , by Region USD Million (2013-2018)
  • Table 14. South America Vital Signs Monitoring, by Country USD Million (2013-2018)
  • Table 15. South America Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 16. South America Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 17. South America Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 18. Brazil Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 19. Brazil Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 20. Brazil Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 21. Argentina Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 22. Argentina Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 23. Argentina Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 24. Rest of South America Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 25. Rest of South America Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 26. Rest of South America Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 27. Asia Pacific Vital Signs Monitoring, by Country USD Million (2013-2018)
  • Table 28. Asia Pacific Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 29. Asia Pacific Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 30. Asia Pacific Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 31. China Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 32. China Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 33. China Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 34. Japan Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 35. Japan Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 36. Japan Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 37. India Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 38. India Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 39. India Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 40. South Korea Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 41. South Korea Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 42. South Korea Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 43. Taiwan Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 44. Taiwan Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 45. Taiwan Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 46. Australia Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 47. Australia Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 48. Australia Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 49. Rest of Asia-Pacific Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 50. Rest of Asia-Pacific Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 51. Rest of Asia-Pacific Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 52. Europe Vital Signs Monitoring, by Country USD Million (2013-2018)
  • Table 53. Europe Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 54. Europe Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 55. Europe Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 56. Germany Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 57. Germany Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 58. Germany Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 59. France Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 60. France Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 61. France Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 62. Italy Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 63. Italy Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 64. Italy Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 65. United Kingdom Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 66. United Kingdom Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 67. United Kingdom Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 68. Netherlands Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 69. Netherlands Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 70. Netherlands Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 71. Rest of Europe Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 72. Rest of Europe Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 73. Rest of Europe Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 74. MEA Vital Signs Monitoring, by Country USD Million (2013-2018)
  • Table 75. MEA Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 76. MEA Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 77. MEA Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 78. Middle East Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 79. Middle East Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 80. Middle East Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 81. Africa Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 82. Africa Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 83. Africa Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 84. North America Vital Signs Monitoring, by Country USD Million (2013-2018)
  • Table 85. North America Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 86. North America Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 87. North America Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 88. United States Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 89. United States Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 90. United States Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 91. Canada Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 92. Canada Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 93. Canada Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 94. Mexico Vital Signs Monitoring, by Application USD Million (2013-2018)
  • Table 95. Mexico Vital Signs Monitoring, by Distribution Chanel USD Million (2013-2018)
  • Table 96. Mexico Vital Signs Monitoring, by Portability USD Million (2013-2018)
  • Table 97. Vital Signs Monitoring Sales: by Application(Units)
  • Table 98. Vital Signs Monitoring Sales Hospitals and Clinics , by Region Units (2013-2018)
  • Table 99. Vital Signs Monitoring Sales Ambulatory Centers , by Region Units (2013-2018)
  • Table 100. Vital Signs Monitoring Sales Home Healthcare , by Region Units (2013-2018)
  • Table 101. Vital Signs Monitoring Sales Others , by Region Units (2013-2018)
  • Table 102. Vital Signs Monitoring Sales: by Distribution Chanel(Units)
  • Table 103. Vital Signs Monitoring Sales Hospital Pharmacy , by Region Units (2013-2018)
  • Table 104. Vital Signs Monitoring Sales Retail Pharmacies , by Region Units (2013-2018)
  • Table 105. Vital Signs Monitoring Sales Online Websites , by Region Units (2013-2018)
  • Table 106. Vital Signs Monitoring Sales Others , by Region Units (2013-2018)
  • Table 107. Vital Signs Monitoring Sales: by Portability(Units)
  • Table 108. Vital Signs Monitoring Sales Standalone , by Region Units (2013-2018)
  • Table 109. Vital Signs Monitoring Sales Portable , by Region Units (2013-2018)
  • Table 110. South America Vital Signs Monitoring Sales, by Country Units (2013-2018)
  • Table 111. South America Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 112. South America Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 113. South America Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 114. Brazil Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 115. Brazil Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 116. Brazil Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 117. Argentina Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 118. Argentina Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 119. Argentina Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 120. Rest of South America Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 121. Rest of South America Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 122. Rest of South America Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 123. Asia Pacific Vital Signs Monitoring Sales, by Country Units (2013-2018)
  • Table 124. Asia Pacific Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 125. Asia Pacific Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 126. Asia Pacific Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 127. China Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 128. China Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 129. China Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 130. Japan Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 131. Japan Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 132. Japan Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 133. India Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 134. India Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 135. India Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 136. South Korea Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 137. South Korea Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 138. South Korea Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 139. Taiwan Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 140. Taiwan Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 141. Taiwan Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 142. Australia Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 143. Australia Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 144. Australia Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 145. Rest of Asia-Pacific Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 146. Rest of Asia-Pacific Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 147. Rest of Asia-Pacific Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 148. Europe Vital Signs Monitoring Sales, by Country Units (2013-2018)
  • Table 149. Europe Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 150. Europe Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 151. Europe Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 152. Germany Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 153. Germany Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 154. Germany Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 155. France Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 156. France Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 157. France Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 158. Italy Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 159. Italy Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 160. Italy Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 161. United Kingdom Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 162. United Kingdom Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 163. United Kingdom Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 164. Netherlands Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 165. Netherlands Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 166. Netherlands Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 167. Rest of Europe Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 168. Rest of Europe Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 169. Rest of Europe Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 170. MEA Vital Signs Monitoring Sales, by Country Units (2013-2018)
  • Table 171. MEA Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 172. MEA Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 173. MEA Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 174. Middle East Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 175. Middle East Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 176. Middle East Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 177. Africa Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 178. Africa Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 179. Africa Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 180. North America Vital Signs Monitoring Sales, by Country Units (2013-2018)
  • Table 181. North America Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 182. North America Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 183. North America Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 184. United States Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 185. United States Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 186. United States Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 187. Canada Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 188. Canada Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 189. Canada Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 190. Mexico Vital Signs Monitoring Sales, by Application Units (2013-2018)
  • Table 191. Mexico Vital Signs Monitoring Sales, by Distribution Chanel Units (2013-2018)
  • Table 192. Mexico Vital Signs Monitoring Sales, by Portability Units (2013-2018)
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Vital Signs Monitoring: by Application(USD Million)
  • Table 204. Vital Signs Monitoring Hospitals and Clinics , by Region USD Million (2019-2024)
  • Table 205. Vital Signs Monitoring Ambulatory Centers , by Region USD Million (2019-2024)
  • Table 206. Vital Signs Monitoring Home Healthcare , by Region USD Million (2019-2024)
  • Table 207. Vital Signs Monitoring Others , by Region USD Million (2019-2024)
  • Table 208. Vital Signs Monitoring: by Distribution Chanel(USD Million)
  • Table 209. Vital Signs Monitoring Hospital Pharmacy , by Region USD Million (2019-2024)
  • Table 210. Vital Signs Monitoring Retail Pharmacies , by Region USD Million (2019-2024)
  • Table 211. Vital Signs Monitoring Online Websites , by Region USD Million (2019-2024)
  • Table 212. Vital Signs Monitoring Others , by Region USD Million (2019-2024)
  • Table 213. Vital Signs Monitoring: by Portability(USD Million)
  • Table 214. Vital Signs Monitoring Standalone , by Region USD Million (2019-2024)
  • Table 215. Vital Signs Monitoring Portable , by Region USD Million (2019-2024)
  • Table 216. South America Vital Signs Monitoring, by Country USD Million (2019-2024)
  • Table 217. South America Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 218. South America Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 219. South America Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 220. Brazil Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 221. Brazil Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 222. Brazil Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 223. Argentina Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 224. Argentina Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 225. Argentina Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 226. Rest of South America Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 227. Rest of South America Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 228. Rest of South America Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 229. Asia Pacific Vital Signs Monitoring, by Country USD Million (2019-2024)
  • Table 230. Asia Pacific Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 231. Asia Pacific Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 232. Asia Pacific Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 233. China Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 234. China Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 235. China Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 236. Japan Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 237. Japan Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 238. Japan Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 239. India Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 240. India Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 241. India Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 242. South Korea Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 243. South Korea Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 244. South Korea Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 245. Taiwan Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 246. Taiwan Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 247. Taiwan Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 248. Australia Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 249. Australia Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 250. Australia Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 251. Rest of Asia-Pacific Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 252. Rest of Asia-Pacific Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 253. Rest of Asia-Pacific Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 254. Europe Vital Signs Monitoring, by Country USD Million (2019-2024)
  • Table 255. Europe Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 256. Europe Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 257. Europe Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 258. Germany Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 259. Germany Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 260. Germany Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 261. France Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 262. France Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 263. France Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 264. Italy Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 265. Italy Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 266. Italy Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 267. United Kingdom Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 268. United Kingdom Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 269. United Kingdom Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 270. Netherlands Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 271. Netherlands Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 272. Netherlands Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 273. Rest of Europe Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 274. Rest of Europe Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 275. Rest of Europe Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 276. MEA Vital Signs Monitoring, by Country USD Million (2019-2024)
  • Table 277. MEA Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 278. MEA Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 279. MEA Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 280. Middle East Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 281. Middle East Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 282. Middle East Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 283. Africa Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 284. Africa Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 285. Africa Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 286. North America Vital Signs Monitoring, by Country USD Million (2019-2024)
  • Table 287. North America Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 288. North America Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 289. North America Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 290. United States Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 291. United States Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 292. United States Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 293. Canada Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 294. Canada Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 295. Canada Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 296. Mexico Vital Signs Monitoring, by Application USD Million (2019-2024)
  • Table 297. Mexico Vital Signs Monitoring, by Distribution Chanel USD Million (2019-2024)
  • Table 298. Mexico Vital Signs Monitoring, by Portability USD Million (2019-2024)
  • Table 299. Vital Signs Monitoring Sales: by Application(Units)
  • Table 300. Vital Signs Monitoring Sales Hospitals and Clinics , by Region Units (2019-2024)
  • Table 301. Vital Signs Monitoring Sales Ambulatory Centers , by Region Units (2019-2024)
  • Table 302. Vital Signs Monitoring Sales Home Healthcare , by Region Units (2019-2024)
  • Table 303. Vital Signs Monitoring Sales Others , by Region Units (2019-2024)
  • Table 304. Vital Signs Monitoring Sales: by Distribution Chanel(Units)
  • Table 305. Vital Signs Monitoring Sales Hospital Pharmacy , by Region Units (2019-2024)
  • Table 306. Vital Signs Monitoring Sales Retail Pharmacies , by Region Units (2019-2024)
  • Table 307. Vital Signs Monitoring Sales Online Websites , by Region Units (2019-2024)
  • Table 308. Vital Signs Monitoring Sales Others , by Region Units (2019-2024)
  • Table 309. Vital Signs Monitoring Sales: by Portability(Units)
  • Table 310. Vital Signs Monitoring Sales Standalone , by Region Units (2019-2024)
  • Table 311. Vital Signs Monitoring Sales Portable , by Region Units (2019-2024)
  • Table 312. South America Vital Signs Monitoring Sales, by Country Units (2019-2024)
  • Table 313. South America Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 314. South America Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 315. South America Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 316. Brazil Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 317. Brazil Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 318. Brazil Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 319. Argentina Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 320. Argentina Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 321. Argentina Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 322. Rest of South America Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 323. Rest of South America Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 324. Rest of South America Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 325. Asia Pacific Vital Signs Monitoring Sales, by Country Units (2019-2024)
  • Table 326. Asia Pacific Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 327. Asia Pacific Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 328. Asia Pacific Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 329. China Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 330. China Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 331. China Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 332. Japan Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 333. Japan Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 334. Japan Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 335. India Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 336. India Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 337. India Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 338. South Korea Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 339. South Korea Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 340. South Korea Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 341. Taiwan Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 342. Taiwan Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 343. Taiwan Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 344. Australia Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 345. Australia Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 346. Australia Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 347. Rest of Asia-Pacific Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 348. Rest of Asia-Pacific Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 349. Rest of Asia-Pacific Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 350. Europe Vital Signs Monitoring Sales, by Country Units (2019-2024)
  • Table 351. Europe Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 352. Europe Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 353. Europe Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 354. Germany Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 355. Germany Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 356. Germany Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 357. France Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 358. France Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 359. France Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 360. Italy Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 361. Italy Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 362. Italy Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 363. United Kingdom Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 364. United Kingdom Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 365. United Kingdom Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 366. Netherlands Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 367. Netherlands Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 368. Netherlands Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 369. Rest of Europe Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 370. Rest of Europe Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 371. Rest of Europe Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 372. MEA Vital Signs Monitoring Sales, by Country Units (2019-2024)
  • Table 373. MEA Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 374. MEA Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 375. MEA Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 376. Middle East Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 377. Middle East Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 378. Middle East Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 379. Africa Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 380. Africa Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 381. Africa Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 382. North America Vital Signs Monitoring Sales, by Country Units (2019-2024)
  • Table 383. North America Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 384. North America Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 385. North America Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 386. United States Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 387. United States Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 388. United States Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 389. Canada Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 390. Canada Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 391. Canada Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 392. Mexico Vital Signs Monitoring Sales, by Application Units (2019-2024)
  • Table 393. Mexico Vital Signs Monitoring Sales, by Distribution Chanel Units (2019-2024)
  • Table 394. Mexico Vital Signs Monitoring Sales, by Portability Units (2019-2024)
  • Table 395. Research Programs/Design for This Report
  • Table 396. Key Data Information from Secondary Sources
  • Table 397. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Vital Signs Monitoring: by Application USD Million (2013-2018)
  • Figure 5. Global Vital Signs Monitoring: by Distribution Chanel USD Million (2013-2018)
  • Figure 6. Global Vital Signs Monitoring: by Portability USD Million (2013-2018)
  • Figure 7. South America Vital Signs Monitoring Share (%), by Country
  • Figure 8. Asia Pacific Vital Signs Monitoring Share (%), by Country
  • Figure 9. Europe Vital Signs Monitoring Share (%), by Country
  • Figure 10. MEA Vital Signs Monitoring Share (%), by Country
  • Figure 11. North America Vital Signs Monitoring Share (%), by Country
  • Figure 12. Global Vital Signs Monitoring: by Application Units (2013-2018)
  • Figure 13. Global Vital Signs Monitoring: by Distribution Chanel Units (2013-2018)
  • Figure 14. Global Vital Signs Monitoring: by Portability Units (2013-2018)
  • Figure 15. South America Vital Signs Monitoring Share (%), by Country
  • Figure 16. Asia Pacific Vital Signs Monitoring Share (%), by Country
  • Figure 17. Europe Vital Signs Monitoring Share (%), by Country
  • Figure 18. MEA Vital Signs Monitoring Share (%), by Country
  • Figure 19. North America Vital Signs Monitoring Share (%), by Country
  • Figure 20. Global Vital Signs Monitoring share by Players 2018 (%)
  • Figure 21. Global Vital Signs Monitoring share by Players (Top 3) 2018(%)
  • Figure 22. Global Vital Signs Monitoring share by Players (Top 5) 2018(%)
  • Figure 23. BCG Matrix for key Companies
  • Figure 24. A&D Company (Japan) Revenue, Net Income and Gross profit
  • Figure 25. A&D Company (Japan) Revenue: by Geography 2018
  • Figure 26. Contec Medical Systems (China) Revenue, Net Income and Gross profit
  • Figure 27. Contec Medical Systems (China) Revenue: by Geography 2018
  • Figure 28. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 29. GE Healthcare (United States) Revenue: by Geography 2018
  • Figure 30. Masimo Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 31. Masimo Corporation (United States) Revenue: by Geography 2018
  • Figure 32. Mindray Medical International Limited (China) Revenue, Net Income and Gross profit
  • Figure 33. Mindray Medical International Limited (China) Revenue: by Geography 2018
  • Figure 34. Nihon Kohden (Japan) Revenue, Net Income and Gross profit
  • Figure 35. Nihon Kohden (Japan) Revenue: by Geography 2018
  • Figure 36. Omron Healthcare, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 37. Omron Healthcare, Inc. (United States) Revenue: by Geography 2018
  • Figure 38. Philips Healthcare (Netherlands) Revenue, Net Income and Gross profit
  • Figure 39. Philips Healthcare (Netherlands) Revenue: by Geography 2018
  • Figure 40. Spacelabs Healthcare, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 41. Spacelabs Healthcare, Inc. (United States) Revenue: by Geography 2018
  • Figure 42. SunTech Medical (United States) Revenue, Net Income and Gross profit
  • Figure 43. SunTech Medical (United States) Revenue: by Geography 2018
  • Figure 44. Global Vital Signs Monitoring: by Application USD Million (2019-2024)
  • Figure 45. Global Vital Signs Monitoring: by Distribution Chanel USD Million (2019-2024)
  • Figure 46. Global Vital Signs Monitoring: by Portability USD Million (2019-2024)
  • Figure 47. South America Vital Signs Monitoring Share (%), by Country
  • Figure 48. Asia Pacific Vital Signs Monitoring Share (%), by Country
  • Figure 49. Europe Vital Signs Monitoring Share (%), by Country
  • Figure 50. MEA Vital Signs Monitoring Share (%), by Country
  • Figure 51. North America Vital Signs Monitoring Share (%), by Country
  • Figure 52. Global Vital Signs Monitoring: by Application Units (2019-2024)
  • Figure 53. Global Vital Signs Monitoring: by Distribution Chanel Units (2019-2024)
  • Figure 54. Global Vital Signs Monitoring: by Portability Units (2019-2024)
  • Figure 55. South America Vital Signs Monitoring Share (%), by Country
  • Figure 56. Asia Pacific Vital Signs Monitoring Share (%), by Country
  • Figure 57. Europe Vital Signs Monitoring Share (%), by Country
  • Figure 58. MEA Vital Signs Monitoring Share (%), by Country
  • Figure 59. North America Vital Signs Monitoring Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • A&D Company (Japan)
  • Contec Medical Systems (China)
  • GE Healthcare (United States)
  • Masimo Corporation (United States)
  • Mindray Medical International Limited (China)
  • Nihon Kohden (Japan)
  • Omron Healthcare, Inc. (United States)
  • Philips Healthcare (Netherlands)
  • Spacelabs Healthcare, Inc. (United States)
  • SunTech Medical (United States)
Additional players considered in the study are as follows:
Welch Allyn, Inc. (United States) , Boston Scientific (United States) , Natus Medical Incorporated (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation